Faeth Therapeutics, Inc.

XNASHealth care

Last traded price · USD

$20.05

+0.30%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 18:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $19.99
Volume: 1
Day's high: —
Day's low: —

In brief

Faeth Therapeutics, Inc. is a health care company listed on Nasdaq, valued at about $518M.
Its shares closed at $19.99 on 4 Nov 2026.
From India you can buy FTH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Faeth Therapeutics, Inc. (FTH) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole FTH share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade FTH options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 3 months
1 month: −25.7% (SPY −1.6%, XLV +13.5%). 3 months: −18.7% (SPY −0.4%, XLV +15.5%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FTH, SPY and XLV · as of 4 Nov 2026
7.8 days to cover short interest
2.3M shares were sold short at the 15 Oct 2026 settlement, 9.0% of the 25.8M shares outstanding; covering them would take 7.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $19.99 was 28.5% below its 50-day average ($27.95).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−25.7%

6 months—

1 year—

5 years—

Newswire

About

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Website

Notable moves

August 10, 2026
+17.14%
July 16, 2026
−17.57%
June 22, 2026
+30.13%

Faeth Therapeutics, Inc.

XNASHealth care

Last traded price · USD

$20.05

+0.30%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 18:25 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $19.99
Volume: 1
Day's high: —
Day's low: —

In brief

Faeth Therapeutics, Inc. is a health care company listed on Nasdaq, valued at about $518M.
Its shares closed at $19.99 on 4 Nov 2026.
From India you can buy FTH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Faeth Therapeutics, Inc. (FTH) shares from India?

Do I need the price of a whole FTH share to invest?

How much can I invest in US stocks in a year?

Can I trade FTH options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 3 months
1 month: −25.7% (SPY −1.6%, XLV +13.5%). 3 months: −18.7% (SPY −0.4%, XLV +15.5%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: FTH, SPY and XLV · as of 4 Nov 2026
7.8 days to cover short interest
2.3M shares were sold short at the 15 Oct 2026 settlement, 9.0% of the 25.8M shares outstanding; covering them would take 7.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50-day average
The 4 Nov 2026 close of $19.99 was 28.5% below its 50-day average ($27.95).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−25.7%

6 months—

1 year—

5 years—

Newswire

About

Website

Notable moves

August 10, 2026
+17.14%
July 16, 2026
−17.57%
June 22, 2026
+30.13%

Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc. in brief

Behind SPY and its sector fund XLV over 3 months

7.8 days to cover short interest

Below its 50-day average

Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc. in brief

Behind SPY and its sector fund XLV over 3 months

7.8 days to cover short interest

Below its 50-day average